Crinetics Pharmaceuticals, Inc. (CRNX) Financial Statements (2024 and earlier)

Company Profile

Business Address 10222 BARNES CANYON ROAD, BLDG. #2
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:334,400333,700170,900118,400163,900
Cash and cash equivalents32,672200,69593,08740,32644,973
Short-term investments301,753133,01277,79378,066118,902
Other undisclosed cash, cash equivalents, and short-term investments(25)(7)20825
Receivables1,4881,052113449568
Prepaid expense939888693  
Other current assets2,5359121,0241,0911,224
Other undisclosed current assets5,8228,1684,7623,399991
Total current assets:345,184344,720177,492123,339166,683
Noncurrent Assets
Operating lease, right-of-use asset1,4861,8922,2322,510
Property, plant and equipment3,5002,8253,1813,9464,232
Restricted cash and investments1,301500500500500
Other noncurrent assets37 4082 
Other undisclosed noncurrent assets6681,078   
Total noncurrent assets:6,9926,2955,9537,0384,732
TOTAL ASSETS:352,176351,015183,445130,377171,415
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:15,3518,4685,5885,4987,925
Employee-related liabilities   2,279
Accounts payable6,883   1,456
Accrued liabilities694   4,190
Other undisclosed accounts payable and accrued liabilities7,7748,4685,5885,498 
Deferred revenue 2,200   
Debt    724 
Other liabilities 1,051939835724 
Other undisclosed current liabilities9,1216,5884,0661,394 
Total current liabilities:27,72315,99510,4898,3407,925
Noncurrent Liabilities
Long-term debt and lease obligation:  3,0744,0144,849 
Liabilities, other than long-term debt8,125223493,265
Deferred revenue6,101   
Deferred compensation liability, classified  22349202
Deferred rent credit     3,063
Operating lease, liability2,0243,0744,0144,849
Total noncurrent liabilities:8,1253,0764,0374,8983,265
Total liabilities:35,84819,07114,52613,23811,190
Equity
Equity, attributable to parent, including:316,328331,944168,919117,139160,225
Common stock     24
Additional paid in capital     203,520
Accumulated other comprehensive income (loss)(3,931)(382)2514861
Accumulated deficit(439,173)(275,255)(167,614)(93,802)(43,380)
Other undisclosed equity, attributable to parent759,432607,581336,508210,793 
Total equity:316,328331,944168,919117,139160,225
TOTAL LIABILITIES AND EQUITY:352,176351,015183,445130,377171,415

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues4,7371,078711,1932,428
Gain on disposition of assets for financial service operations  2,000   
Gross profit:4,7371,078711,1932,428
Operating expenses(172,619)(108,780)(75,024)(55,025)(31,138)
Operating loss:(167,882)(107,702)(74,953)(53,832)(28,710)
Nonoperating income4,974611,1413,4101,595
Investment income, nonoperating4,3171579913,4601,748
Loss from continuing operations before equity method investments, income taxes:(162,908)(107,641)(73,812)(50,422)(27,115)
Other undisclosed loss from continuing operations before income taxes(1,010)    
Loss from continuing operations:(163,918)(107,641)(73,812)(50,422)(27,115)
Loss before gain (loss) on sale of properties:(107,641)(73,812)(50,422)(27,115)
Net loss:(163,918)(107,641)(73,812)(50,422)(27,115)
Other undisclosed net income attributable to parent     
Net loss available to common stockholders, diluted:(163,918)(107,641)(73,812)(50,422)(27,115)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(163,918)(107,641)(73,812)(50,422)(27,115)
Other comprehensive income (loss)(3,549)(407)(123)8761
Comprehensive loss:(167,467)(108,048)(73,935)(50,335)(27,054)
Other undisclosed comprehensive income, net of tax, attributable to parent     
Comprehensive loss, net of tax, attributable to parent:(167,467)(108,048)(73,935)(50,335)(27,054)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: